CCR2 and ductal breast carcinoma in situ: The DCIS.com MIND model has been demonstrated to be a reliable and physiologically relevant model of DCIS progression.33,42 To target CCR2, mice were MIND injected with CCR2 knockout (CCR2-KO) and compared control DCIS.com cells expressing wildtype CCR2 (WT).